LHC Group (NASDAQ:LHCG) had its price target lowered by Truist from $240.00 to $185.00 in a research note published on Wednesday, The Fly reports. The brokerage currently has a buy rating on the health services provider’s stock.
Other analysts have also issued research reports about the company. Truist Securities lowered their target price on LHC Group from $240.00 to $185.00 and set a buy rating for the company in a report on Wednesday. Credit Suisse Group decreased their price objective on LHC Group from $255.00 to $252.00 and set an outperform rating for the company in a report on Tuesday, August 10th. Benchmark increased their price objective on LHC Group from $250.00 to $260.00 and gave the company a buy rating in a report on Friday, July 9th. UBS Group assumed coverage on LHC Group in a report on Thursday, September 23rd. They set a neutral rating and a $170.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on LHC Group from $260.00 to $245.00 and set a buy rating for the company in a report on Wednesday, September 22nd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of Buy and a consensus target price of $211.64.
Shares of NASDAQ:LHCG opened at $142.63 on Wednesday. LHC Group has a 52-week low of $133.74 and a 52-week high of $236.81. The stock has a market cap of $4.52 billion, a P/E ratio of 38.24, a price-to-earnings-growth ratio of 1.93 and a beta of 0.36. The business’s 50 day moving average is $169.93 and its 200 day moving average is $190.85.
A number of institutional investors and hedge funds have recently made changes to their positions in LHCG. Cullen Frost Bankers Inc. grew its position in LHC Group by 568.6% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 234 shares of the health services provider’s stock worth $47,000 after purchasing an additional 199 shares during the period. Liberty Wealth Management LLC grew its position in LHC Group by 21,038.9% during the 2nd quarter. Liberty Wealth Management LLC now owns 11,415 shares of the health services provider’s stock worth $57,000 after purchasing an additional 11,361 shares during the period. Eubel Brady & Suttman Asset Management Inc. acquired a new stake in LHC Group during the 2nd quarter worth about $57,000. Heritage Wealth Management LLC grew its position in LHC Group by 55.1% during the 2nd quarter. Heritage Wealth Management LLC now owns 307 shares of the health services provider’s stock worth $61,000 after purchasing an additional 109 shares during the period. Finally, Van ECK Associates Corp acquired a new stake in LHC Group during the 2nd quarter worth about $74,000. 92.14% of the stock is currently owned by institutional investors.
About LHC Group
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
Featured Article: Debt-To-Equity Ratio
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.